| Document Date: 2014-08-21 13:04:53
Open Document File Size: 435,16 KBShare Result on Facebook
City Barcelona / Fort Worth / / Company Novartis / ALCON CUSI S.A. / Alcon Laboratories Inc. / Ames / / Country United States / Spain / / Currency pence / / Event FDA Phase / / Facility Storage Store / / IndustryTerm machinery / mg oral solution / nonsterile aqueous solution / aqueous solution / metered-spray solution / chemical name / nasal spray solution / chemical structure / / MedicalCondition anosmia / headache / urinary tract infection / perennial allergic rhinitis / rhinitis / nasal disease / Fatigue / drowsiness / seasonal allergic rhinitis / diarrhea / restlessness / Local Nasal Effects Epistaxis / wheezing / upper respiratory tract infection / Epistaxis / pneumonia / dysgeusia / Carcinogenesis / nasal congestion / Older Adverse Reaction Bitter taste Headache Epistaxis Pharyngolaryngeal Pain Post-nasal drip Cough Urinary tract infection CPK / allergy / pain / concomitant disease / allergic rhinitis / dizziness / cough / Depression / rash / / MedicalTreatment drug therapy / / Organization DOSAGE AND ADMINISTRATION / FDA / / Person Nasal Spray / / / Position representative / / Product sodium chloride / edetate disodium / olopatadine hydrochloride / acetic acid / AUC0-12 / / ProvinceOrState Texas / / PublishedMedium Baseline / / Technology Pharmacokinetics / Pharmacodynamics / / URL www.fda.gov/medwatch / /
SocialTag |
These highlights do not include all the information needed to use PATANASE® Nasal Spray safely and effectively. See full prescribing information for PATANASE Nasal Spray. PATANASE (olopatadine hydrochloride) Nasal Spray